title: The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
abstract: In adult-onset Huntington's disease (HD), striatal projection neurons are much more vulnerable than striatal interneurons, but even striatal projection neurons show differences in their vulnerability, with the striatal projection neurons projecting to the internal segment of the globus pallidus being the least vulnerable. Previous studies have shown that systemic chronic treatment with 3-nitropropionic acid (3NP), an inhibitor of succinate dehydrogenase, induces the preferential loss of striatal projection neurons over striatal interneurons that is characteristic of HD, which has been taken to support the hypothesis that the pathogenic defect in HD may involve impaired energy metabolism. We sought to determine whether the patterns of survival for striatal projection neurons in 4-month-old rats after chronic systemic 3NP treatment also resemble those in adult-onset HD. We assessed the projection neuron survival using neuropeptide immunolabeling of striatal efferent fibers in striatal target areas and quantified the degree of fiber loss in the striatal target areas using computer-assisted image analysis. We found that 3NP produced relatively equal loss of striatal fibers and terminals in the globus pallidus, substantia nigra, and entopeduncular nucleus, indicating a nondifferential vulnerability of striatal projection neurons to 3NP-induced impairment in energy metabolism. The results suggest that the 3NP rat model does not fully mimic adult-onset HD pathogenesis.
authors.affiliation: Department of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Sun
authors.forename: J
authors.initials: J
authors.lastname: Xie
authors.forename: A
authors.initials: A
authors.lastname: Reiner
mesh_terms: D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects / Q000473:pathology*; D004195:Disease Models, Animal; D020392:Entopeduncular Nucleus / Q000187:drug effects / Q000473:pathology; D005917:Globus Pallidus / Q000187:drug effects / Q000473:pathology; D006816:Huntington Disease / Q000473:pathology*; D007395:Interneurons / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D009252:NADPH Dehydrogenase / Q000096:biosynthesis; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D009574:Nitro Compounds; D011422:Propionates; D051381:Rats; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results; D013378:Substantia Nigra / Q000187:drug effects / Q000473:pathology
chemical_list: D009574:Nitro Compounds; D011422:Propionates; D009252:NADPH Dehydrogenase; C015392:3-nitropropionic acid